Trial Profile
Effects of statin monotherapy versus statin + ezetimibe on non-calcified coronary plaque (NCCP) assessed by computed tomography angiography in patients with stable angina pectoris with and without metabolic syndrome
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Oct 2015
Price :
$35
*
At a glance
- Drugs Ezetimibe (Primary) ; HMG-CoA reductase inhibitors
- Indications Angina pectoris; Atherosclerosis; Metabolic syndrome
- Focus Therapeutic Use
- 21 Oct 2015 New trial record
- 02 Sep 2015 Results presented at ESC Congress 2015: Annual Congress of the European Society of Cardiology.